Skip to content

Clinical trials

Schizophrenia trials in Serbia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Country / region: Serbia Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20061
20072
20082
20093
20102
20114
20122
20131
20151
20165
20174
20181
20194
20203
20216
20222
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Terminated7
Recruiting5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.12
Neurocrine Biosciences5
ACADIA Pharmaceuticals Inc.4
Alkermes, Inc.3
Boehringer Ingelheim3
H. Lundbeck A/S3
Sumitomo Pharma America, Inc.3
AstraZeneca2
FORUM Pharmaceuticals Inc2
Intra-Cellular Therapies, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia49
Bipolar Disorder2
Cognitive Dysfunction2
Psychotic Disorders2
Autism Spectrum Disorder1
Central Nervous System Diseases1
Cognition Disorders1
Mania1
Recurrence1

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.